Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What size range is anticipated for the Transcatheter Mitral Valve Market from 2026 to 2030?
The transcatheter mitral valve market size has demonstrated significant growth in recent years. It is projected to increase from $1.61 billion in 2025 to $1.76 billion in 2026, representing a compound annual growth rate (CAGR) of 9.3%. Historically, this expansion has been driven by the limited availability of transcatheter mitral valves, the continued reliance on surgical valve replacement, growing awareness of mitral valve disease, an increase in hospital cardiac procedures, and early adoption in high-risk patient groups.
The transcatheter mitral valve market size is projected for robust expansion over the coming years, anticipated to reach $2.49 billion by 2030 with a compound annual growth rate (CAGR) of 9.0%. This anticipated growth during the forecast period is primarily attributable to several factors, including advancements in transcatheter valve design technology, an increasing elderly population affected by mitral valve disorders, the proliferation of cardiac catheterization laboratories, rising healthcare spending, and the uptake of minimally invasive cardiac intervention initiatives. Key trends during this period encompass the growing acceptance of minimally invasive cardiac procedures, a wider application of self-expanding and balloon-expandable valves, the extension of edge-to-edge and chordal repair device availability, an increasing occurrence of mitral valve diseases among older patients, and the incorporation of imaging and navigation systems to enhance procedural accuracy.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27437&type=smp
What Drivers Are Affecting Demand In The Transcatheter Mitral Valve Market?
The rising occurrence of heart diseases is anticipated to propel the future expansion of the transcatheter mitral valve market. These conditions are disorders that disrupt the heart’s structure or function, thereby diminishing its efficiency in pumping blood. The escalating prevalence of heart diseases is primarily fueled by aging populations, as age-related deterioration of the heart and blood vessels increases vulnerability to conditions such as mitral valve regurgitation, heart failure, and arrhythmias. A transcatheter mitral valve aids in treating heart disease by repairing or replacing a damaged mitral valve to restore healthy blood flow between the heart’s chambers, ultimately improving heart function and easing symptoms. For instance, in August 2025, according to the National Center for Biotechnology Information, a US-based governmental agency, cardiovascular disease is projected to rise significantly between 2025 and 2050. This period is expected to see prevalence increase by 90.0%, crude mortality by 73.4%, and crude DALYs by 54.7%, culminating in an estimated 35.6 million cardiovascular deaths in 2050, a notable increase from 20.5 million in 2025. Therefore, the growing prevalence of heart diseases is a key driver for the transcatheter mitral valve market’s growth.
Which Segment Groups Are Influencing The Transcatheter Mitral Valve Market?
The transcatheter mitral valve market covered in this report is segmented –
1) By Product: Transcatheter Mitral Valve Replacement, Transcatheter Mitral Valve Repair
2) By Indication: Mitral Stenosis, Mitral Regurgitation
3) By End-User: Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories
Subsegments:
1) By Transcatheter Mitral Valve Replacement: Self-Expanding Valves, Balloon-Expandable Valves
2) By Transcatheter Mitral Valve Repair: Annuloplasty Devices, Chordal Repair Devices, Edge-To-Edge Repair Devices
What Trends Are Projected To Support The Growth Of The Transcatheter Mitral Valve Market?
Major companies in the transcatheter mitral valve market are concentrating on developing advanced products, such as transcatheter mitral valve replacement systems, to expand treatment options for high-risk or inoperable patients. Transcatheter mitral valve replacement (TMVR) systems are defined as minimally invasive medical devices that replace a damaged or diseased mitral valve in the heart with an artificial valve using a catheter-based approach, thus avoiding the need for open-heart surgery. For instance, in May 2025, Abbott Laboratories, a US-based medical device company, introduced Tendyne, which secured approval from the Food and Drug Administration (FDA). This particular valve is self-expanding, features a nitinol frame, and is available in multiple sizes to accommodate varied anatomies, allowing for full repositioning or retrieval during implantation. Delivered through a small incision in the chest, the system facilitates a minimally invasive procedure typically completed in about 1.5 hours. Designed for faster recovery, the system enables most patients to be discharged within three days, offering a transformative solution for high-risk mitral valve patients who lack viable surgical alternatives.
Who Are The Prominent Global Companies Shaping The Transcatheter Mitral Valve Market Landscape?
Major companies operating in the transcatheter mitral valve market are Abbott Laboratories, Medtronic Inc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Meril Life Sciences Private Limited, MicroPort Scientific Corporation, Venus Medtech Inc., Cardiac Dimensions Inc., JenaValve Technology Inc., Ancora Heart Inc, Peijia Medical Limited, Micro Interventional Devices Inc., 4C Medical Technologies Inc., NeoChord Inc., Xeltis AG, Valcare Medical Inc., Colibri Heart Valve LLC, MitrAssist Ltd., HighLife SAS, Navigate Cardiac Structures Inc., Cardiovalve Ltd.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/transcatheter-mitral-valve-global-market-report
Which Region Is Projected To Lead The Transcatheter Mitral Valve Market During The Forecast Period?
North America was the largest region in the transcatheter mitral valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcatheter mitral valve market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Transcatheter Mitral Valve Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27437&type=smp
Browse Through More Reports Similar to the Global Transcatheter Mitral Valve Market 2026, By The Business Research Company
Titanium Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/titanium-global-market-report
Carbon Nanomaterials Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/carbon-nanomaterials-global-market-report
Aerospace Titanium Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/aerospace-titanium-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company